Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,600
Closed -$1.49M 3961
2021
Q4
$1.49M Sell
5,600
-800
-13% -$232K ﹤0.01% 2200
2021
Q3
$1.82M Buy
6,400
+100
+2% +$28.5K ﹤0.01% 2078
2021
Q2
$1.73M Buy
6,300
+4,300
+215% +$1.17M ﹤0.01% 1992
2021
Q1
$522K Sell
2,000
-3,700
-65% -$991K ﹤0.01% 2889
2020
Q4
$1.46M Buy
5,700
+1,800
+46% +$447K ﹤0.01% 1720
2020
Q3
$923K Sell
3,900
-1,200
-24% -$253K ﹤0.01% 1817
2020
Q2
$991K Sell
5,100
-1,400
-22% -$268K ﹤0.01% 1543
2020
Q1
$1.08M Buy
+6,500
New +$1.19M 0.01% 1353

Other funds holding PODD

John Overdeck's PODD Position: Q2 2026 in Review

John Overdeck increased its Insulet (PODD) stake by 150% in Q2 2026, buying an estimated $190M and bringing the position to 1,903,734 shares worth $290M. The position accounts for 0.21% of the portfolio, ranked #98.

John Overdeck first reported a position in PODD in Q2 2013 and has held it in 32 quarters since. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • John Overdeck held 1,903,734 shares of Insulet worth $290M as of Q2 2026.
  • John Overdeck bought 1,141,385 Insulet shares in Q2 2026, an estimated $190M.
  • Insulet made up 0.21% of John Overdeck's portfolio in Q2 2026, its #98 holding.
  • John Overdeck first reported a position in Insulet in Q2 2013 and has held it in 32 quarters since.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.